Health officials removed certification for a regional organ procurement group after federal reviews found repeated patient-safety failures, including cases where donation pathways began while people still showed signs of life.
The New York Times investigation last year raised alarm about how the push to increase organ transplants may have compromised basic patient protections, and those findings set off federal scrutiny that turned serious. Reporters documented cases where organ procurement teams and some providers pressed forward even when patients displayed neurological signs inconsistent with death. Those stories made people and regulators alike demand answers and accountability from the system that manages life-and-death decisions.
Two cases from that reporting stand out as stark reminders of risk. A woman named Danella Gallegos was in a pre-surgery room when a doctor asked her to blink, and she did, later making a full recovery. Misty Hawkins choked while eating and went into a coma; surgeons later found her heart still beating when donation efforts had already begun. These are not abstract problems; they are real patients who were nearly presumed gone while still showing signs of life.
Federal review teams dug into a large sample of troubling cases and found patterns that no one should accept. Of 351 instances where donation was authorized but not completed, reviewers flagged 103 as having “concerning features” and identified at least 28 patients who may not have been deceased when procurement was initiated. The report also pointed to poor neurological assessments, weak coordination with treating medical teams, and questionable consent practices—systemic weaknesses that demand action, not platitudes.
Those findings prompted Health and Human Services Secretary Robert F. Kennedy Jr. to act. “I am announcing that HHS has become the decertification of Network for Hope, the organ procurement organization serving Kentucky and parts of Indiana, Ohio, and West Virginia. We reached this decision after extensive reviews by CMS and HRSA found persistent patient safety failures despite repeated oversight, repeated warnings, corrective action plans, and multiple opportunities to improve,” Kennedy said.
“Federal reviewers found serious deficiencies in nearly 30 percent of the cases that they examined,” he continued. “We found patients placed on the organ donation pathway who should have never been there. We found cases with a donation process continued despite signs the patients were not appropriate organ donors. We found repeated failures in clinical judgment, oversight, and patient safety.”
The HHS move strips Network for Hope of its federal certification, a serious step that effectively removes its authority to coordinate organ recovery under the current rules. For people who had been following the scandal, this feels like a corrective long overdue. When an organization shows repeated failures after warnings and corrective plans, regulators have no choice but to remove the badge of trust that allows them to operate in vulnerable moments.
https://x.com/nicksortor/status/2085085701159412200
“We found that these problems continued even after the organization promised to correct them. These failures had real consequences. One of those cases involved DJ Hoover. DJ showed signs of awareness while on the operating table about to have his organs removed. Physicians refused to proceed with the organ recovery because they believed that he was still alive. Because they acted, DJ is alive and is here with us today,” Kennedy said.
That account of DJ Hoover underscores why oversight matters. When clinicians refused to proceed because they believed a patient still had awareness, their action saved a life. It also exposed how close the system had come to making catastrophic errors driven by pressure to recover organs. The public deserves a process where medical judgment, careful neurology exams, and informed consent come before quotas or metrics.
Decertifying a regional procurement group is not a symbolic move; it forces the transplant system to re-evaluate how organ donation is managed and who is trusted to do it. For families who might face end-of-life decisions, it should send a message that authorities will intervene when patient safety is compromised. For the transplant field, it must be a wake-up call to tighten clinical protocols, improve oversight, and rebuild trust with patients and clinicians alike.
